Cargando…

What we know and still ignore on COVID‐19 immune pathogenesis and a proposal based on the experience of allergic disorders

The coronavirus disease 2019 (COVID‐19) pandemic started in March 2020 and caused over 5 million confirmed deaths worldwide as far August 2021. We have been recently overwhelmed by a wide literature on how the immune system recognizes severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maggi, Enrico, Azzarone, Bruno Giuseppe, Canonica, Giorgio Walter, Moretta, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652765/ https://www.ncbi.nlm.nih.gov/pubmed/34582050 http://dx.doi.org/10.1111/all.15112

Ejemplares similares

COVID-19: Unanswered questions on immune response and pathogenesis
por: Maggi, Enrico, et al.
Publicado: (2020)

Pathogenic Mechanisms of Vaccine-Induced Immune Thrombotic Thrombocytopenia in People Receiving Anti-COVID-19 Adenoviral-Based Vaccines: A Proposal
por: Azzarone, Bruno, et al.
Publicado: (2021)

Secondary electron yield of surfaces: what we know and what we still need to know
por: Taborelli, M
Publicado: (2020)

Investigating emotions in Parkinson's disease: what we know and what we still don't know
por: Sotgiu, Igor, et al.
Publicado: (2013)

Cholesterol-to-Coprostanol Conversion by the Gut Microbiota: What We Know, Suspect, and Ignore
por: Juste, Catherine, et al.
Publicado: (2021)

Asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

What we still don't know about AIDS
por: Robertson, Miranda
Publicado: (2009)

Erratum: asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

MicroRNAs and cancer: what we know and what we still have to learn
por: Calin, George A
Publicado: (2009)

Phytochemical Molluscicides and Schistosomiasis: What We Know and What We Still Need to Learn
por: Augusto, Ronaldo de Carvalho, et al.
Publicado: (2018)

Circulating RNA in Kidney Cancer: What We Know and What We Still Suppose
por: Cinque, Alessandra, et al.
Publicado: (2021)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
por: Goldstein, David S.
Publicado: (2021)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

Environmental Forces that Shape Early Development: What We Know and Still Need to Know
por: Shankar, Kartik, et al.
Publicado: (2017)

Thoughts on NGS, alternative splicing and what we still need to know
por: Lynch, Kristen W.
Publicado: (2015)

The Gonadotropin-Inhibitory Hormone: What We Know and What We Still Have to Learn From Fish
por: Di Yorio, María P., et al.
Publicado: (2019)

The FIRE AND ICE Trial: What We Know, What We Can Still Learn, and What We Need to Address in the Future
por: Kuck, Karl‐Heinz, et al.
Publicado: (2018)

Plant hormone transporters: what we know and what we would like to know
por: Park, Jiyoung, et al.
Publicado: (2017)

Bleeding after percutaneous coronary intervention: can we still ignore the obvious?
por: Shuvy, Mony, et al.
Publicado: (2014)

The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep
por: Accurso, Vincenzo, et al.
Publicado: (2020)

Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered
por: Plaz Torres, Maria Corina, et al.
Publicado: (2019)

Opinion: PARP inhibitors in cancer—what do we still need to know?
por: Wicks, Andrew J., et al.
Publicado: (2022)

Antimicrobial Mouthwashes: An Overview of Mechanisms—What Do We Still Need to Know?
por: Brookes, Zoë, et al.
Publicado: (2023)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

Molecular Pathology of ALS: What We Currently Know and What Important Information Is Still Missing
por: Jankovska, Nikol, et al.
Publicado: (2021)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

Membrane fission by dynamin: what we know and what we need to know
por: Antonny, Bruno, et al.
Publicado: (2016)

International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020)

Therapeutic Use of the Ketogenic Diet in Refractory Epilepsy: What We Know and What Still Needs to Be Learned
por: Zarnowska, Iwona Maria
Publicado: (2020)

Allergic Rhinitis: What Do We Know About Allergen-Specific Immunotherapy?
por: Boonpiyathad, Tadech, et al.
Publicado: (2021)

Cases of allergic coronary syndrome (Kounis syndrome) : what we should know
por: Akbaş, Türkay, et al.
Publicado: (2022)

“Tau Oligomers,” What We Know and What We Don’t Know
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Epigenetics in Schistosomes: What We Know and What We Need Know
por: Liu, Weiwei
Publicado: (2016)

Portion Size: What We Know and What We Need to Know
por: Benton, David
Publicado: (2015)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Metabolic syndrome: what we know and what we need to know
por: Soares, Raquel
Publicado: (2020)

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
por: Zelek, Wioleta M., et al.
Publicado: (2023)

Commentary: Is this a case in which we know what we don't know what we don't know?
por: Nantsios, Alex, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u40d988dn4j3oictead229pghq